Can I receive the COVID-19 vaccine while taking tuberculosis medication?
Generally, individuals with tuberculosis (TB) can receive the COVID-19 vaccine if their condition is stable and there are no contraindications to vaccination. However, vaccination should be postponed during active disease or if adverse reactions are present. If in doubt, it is recommended to consult a healthcare provider in advance. Detailed explanations are as follows:

If a TB patient's condition has stabilized after treatment, without signs of active disease such as fever or worsening cough, and if liver and kidney functions are normal and there is no history of vaccine allergy, vaccination may be administered after medical evaluation. At this stage, the body is generally capable of tolerating the immune stimulation from the vaccine, allowing effective protection to develop without significantly affecting the ongoing TB treatment.
Vaccination should be delayed if TB is in the active phase—characterized by persistent high fever, hemoptysis (coughing up blood), or difficulty breathing—or if the patient is experiencing adverse drug reactions. During active TB, immune function is compromised; administering the vaccine may exacerbate symptoms and potentially impair the development of an adequate immune response. Vaccination should only be reconsidered once the disease is under control and adverse reactions have resolved.
Prior to vaccination, patients must fully inform their doctor about their TB treatment status and overall health condition for professional assessment of vaccine suitability. After vaccination, they should remain under observation for an adequate period and closely monitor for any physical reactions. It is essential to strictly follow medical instructions and continue taking prescribed TB medications—vaccination should not lead to self-discontinuation of treatment—to ensure comprehensive protection for health.